Why Is EyePoint Pharmaceuticals (EYPT) Stock Down 69% Today?
EyePoint Pharmaceuticals stock was down 69.19% on Monday after a clinical trial update failed to impress investors.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Levin Capital Strategies John A. Levin | 88,000 | $287,760 | +364% | 0.02% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.93 | 10,600 | $52,258.00 | 49,100 | 2026-08-18 | Filing | |
| $13.15 | 1,500 | $19,723.80 | 100,665 | 2026-03-16 | Filing | |
| $5.99 | 5,000 | $29,950.00 | 36,500 | 2025-05-19 | Filing | |
| $5.81 | 5,000 | $29,050.00 | 31,500 | 2025-05-16 | Filing | |
| $5.47 | 5,000 | $27,350.00 | 26,500 | 2025-05-15 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.02 | 2,438 | $36,611.93 | 0 | 2026-06-30 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 2,438 | 2026-06-30 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-04-17 | Filing | |
| $17.87 | 2,438 | $43,571.69 | 0 | 2026-03-04 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-02-17 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 772,803 | $2,536,299 | 0.01% | |
| 2. | 194,598 | $636,335 | 0.06% | |
| 3. | 168,847 | $552,130 | 0.02% | |
| 4. | 119,400 | $390,438 | 0% | |
| 5. | 117,878 | $385,461 | 0.06% |